Shanghai Pharmaceuticals Signs 2026 Sales and Procurement Agreement with Yunnan Baiyao

Shanghai Pharmaceuticals Signs 2026 Sales and Procurement Framework Agreement

Shanghai Pharmaceuticals Says It Plans to Renew Framework Agreement With Yunnan Baiyao, With Sales to Yunnan Baiyao Capped at 1.2 Bln Yuan, Purchases Capped at 700 Mln Yuan for 2026

BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan Baiyao

Yunnan Baiyao Group Honored as Best Practice in Board Office for Three Consecutive Years

Yunnan Baiyao Group Wins CGMA "Best Management Accounting Practice of the Year" Award, Showcasing Industry Leadership

BRIEF-Yunnan Baiyao Elects Zhang Wenxue As Chairman

Yunnan Baiyao Says Board Elects Zhang Wenxue as Co Chairman

Yunnan Baiyao's Attributable Profit Increases Marginally in Q3

Yunnan Baiyao Group Co.,Ltd. (000538.SZ) Reports Q3 Results with Net Profit of RMB 4.78 Billion, Up 10.41% YoY

Yunnan Baiyao Q3 Net Profit up 0.6% Y/Y

BRIEF-Yunnan Baiyao Q3 Net Profit Up 0.6% Y/Y

"High Sales, Low Profits": Yunnan Baiyao Derives 60% of Revenue from Low-Margin Commercial Business

Yunnan Baiyao Group: Yunnan Baiyao Capsules Commonly Used for Traumatic Injuries and Blood Stasis

Yunnan Baiyao Group's Toothpaste Smart Factory Recognized as 2025 Yunnan Province Advanced Intelligent Factory

Yunnan Baiyao Says Some Shares to Serve as Security for Shareholder's Planned Bond Issue

World's First Traditional Chinese Medicine Health Products Lighthouse Factory Established at Yunnan Baiyao Group Co.,Ltd.

Yunnan Baiyao Group Selected as National MIIT Cybersecurity Case Study for New Industrialization

Yunnan Baiyao: Industrial Revenue Share Increases in H1, Company to Boost R&D and Market Expansion in H2

Yunnan Baiyao Group Announces Dividend Distribution of 10.19 Yuan per 10 Shares